Specific GI syndromes linked to Parkinson’s disease
Aug 25, 2023
Gastroparesis, dysphagia, constipation and IBS without diarrhea are associated with PD in case-control, cohort analyses.
Allopurinol may cut risk for neurodegenerative diseases
May 19, 2023
Allopurinol linked to 13 to 34 percent lower risk for Parkinson disease, Alzheimer disease, ALS
Physical activity level inversely linked to Parkinson’s disease in women
May 18, 2023
Incidence of Parkinson’s disease decreased with increasing latent physical activity in a cohort of women.
AI tool diagnoses Parkinson’s years early with 96 percent accuracy
By
John Roszkowski
May 15, 2023
Researchers say a new machine-learning tool shows great promise in detecting Parkinson’s disease years before the first symptoms of the disease start appearing.
The high sensitivity and specificity seen for Parkinson’s disease; α-synuclein SAA also can detect prodromal individuals.
ENT-01 safe, improves constipation in patients with Parkinson’s disease
Nov 07, 2022
Improvement was seen in the weekly complete spontaneous bowel movement rate and in secondary end points
.
‘First-ever’ legislation to end Parkinson’s disease introduced in House
By
Lois A. Bowers
Aug 01, 2022
A bipartisan bill that the Michael J. Fox Foundation for Parkinson’s Research is calling “the first-ever legislation solely devoted to ending Parkinson’s disease” has been introduced in the House...
Older adults using statins have reduced risk of parkinsonism
Mar 23, 2022
The lower risk of parkinsonism was partly mediated by a reduced odds of brain atherosclerosis.
Flavonoid intake linked to mortality risk in Parkinson’s disease
Jan 28, 2022
Higher flavonoid intake after a diagnosis of Parkinson disease is linked to a reduced risk for all-cause mortality.
Relapse risk for psychosis in dementia lower with continued pimavanserin
Jul 22, 2021
The findings were seen in a double-blind, randomized, placebo-controlled discontinuation trial that was stopped early for efficacy.